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Background:  Gender influences mortality after valvular surgery (VS) but its impact on health-related quality of life (HQOL), a major goal of VS, is 
ill-defined. Also undefined are the main and interactive effects of preop health-related coping strategies, social support, ejection fraction (EF), and 
clinical variables on HQOL changes after VS.
Methods:  29 men and 21 women (avg age at surgery 66±16 years) undergoing VS completed the Minnesota Living with Heart Failure 
Questionnaire (MLHFQ), the SF-36 HQOL instrument (both preop and at 6mos postop), and the Jaloweic Coping Scale (JCS) and Interpersonal 
Support Evaluation List (ISEL) (both preop). Presence of preop heart failure (HF) symptoms, coronary artery disease and overall comorbidity also 
were evaluated. T-tests (unpaired and paired) compared men and women at each time point and over time on all MLHFQ and SF-36 composite and 
scale scores; the General Linear Model was used to evaluate the main and interactive effects on pre- to 6-month postop HQOL change of JCS and 
ISEL scores, preop clinical variables, EF and preop HQOL.
Results:  Preop, women had poorer MLHFQ scores (p<=.03, all) and poorer SF-36 physical composite, physical/social functioning, physical role 
and vitality scores (p<=.03, all) vs men. By 6 months postop, men and women’s HQOL were comparable (NS, all scores). Women’s HQOL at 6 months 
improved from preop levels on all MLHFQ scores and on SF-36 physical functioning/role/vitality scores (p=.007 to .035); men’s HQOL improvement was 
not significant (NS, all scores). HQOL improvement was associated with poorer HQOL preop (p=.003 to <.001, all scores, all pts) and presence of preop 
HF in women (p=.006, MLHFQ physical dimension score), but not with preop JCS or ISEL scores, EF, age or other clinical variables (NS, all pts).
Conclusions:  HQOL in women before VS (but not midterm) is inferior to men’s. Their relative HQOL benefit from VS is explained by less favorable preop 
HQOL and presence of HF symptoms, but not by other preop clinical variables, coping strategies or social support. Clinicians should consider gender 
differences on postop HQOL outcomes, as well as the impact of preop HQOL and HF symptoms in women, when counseling pts undergoing VS.
